Exhaled monitoring of CO: validation of the Smokelyzer monitor

E. Canturri, A. Moreno, M. Lujan, H. Espuelas, M. Arranz, C. Domingo (Sabadell, Spain)

Source: Annual Congress 2006 - Respiratory function assessment
Session: Respiratory function assessment
Session type: Poster Discussion
Number: 4974
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Canturri, A. Moreno, M. Lujan, H. Espuelas, M. Arranz, C. Domingo (Sabadell, Spain). Exhaled monitoring of CO: validation of the Smokelyzer monitor. Eur Respir J 2006; 28: Suppl. 50, 4974

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled NO and other gases as biomarkers
Source: Annual Congress 2003 - PG18 - Markers of inflammation in obstructive airway disease
Year: 2003

Exhaled CO measurement for detection of lung diffusion disturbances
Source: Eur Respir J 2003; 22: Suppl. 45, 280s
Year: 2003

Exhaled NO and exhaled breath condensate pH in the assessment of asthma control: a real-life study
Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma
Year: 2009



Exhaled breath collection by electronic nose: methods of measurement
Source: Eur Respir J 2006; 28: Suppl. 50, 790s
Year: 2006

Exhaled air analysis
Source: International Congress 2016 – New tools for the early diagnosis of acute respiratory distress syndrome
Year: 2016


Exhaled gases
Source: Annual Congress 2009 - PG8 Asthma: monitoring airway disease
Year: 2009



Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 423s
Year: 2002

Exhaled carbon monoxide: mechanisms and clinical applications
Source: Eur Respir Monogr 2010; 49: 82-95
Year: 2010


Exhaled breath CO and induced sputum in noninvasive assessment of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 457s
Year: 2003

Feasibility and repeatability of fractional exhaled nitric oxide (FENO) measurements using a new hand-held NO monitoring device in general practice
Source: Eur Respir J 2006; 28: Suppl. 50, 791s
Year: 2006

Technical problems with measurements of biomarkers - exhaled breath condensate
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Comparison of two automated cooximetry system for measurement of carbon monoxide and carboxyhemoglobin in the exhaled air
Source: Eur Respir J 2006; 28: Suppl. 50, 389s
Year: 2006

Reliability of a new portable device for the measurement of fractional exhaled nitric oxide (FeNO)
Source: Annual Congress 2010 - Innovations in the assessment of airway diseases
Year: 2010


Exhaled nitric oxide measurement with portable analyser in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007

pH measurement in exhaled breath condensate: a comparison between two collection devices
Source: Eur Respir J 2006; 28: Suppl. 50, 790s
Year: 2006

Short-term repeatability of fractional exhaled nitric oxide (FENO) measurement in children
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016

Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition?
Source: Eur Respir J 2004; 24: Suppl. 48, 386s
Year: 2004

Future perspectives on exhaled biomarkers
Source: Eur Respir Monogr 2010; 49: 237-246
Year: 2010